Solitary Fibrous Tumor

subtype

Identifier: CI-CAN-00001539
Entity page: /cancer/solitary-fibrous-tumor ↗
Edges: 50

Neighbours: 18 drugs10 trials
Drawn: 28 of 28 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Solitary Fibrous Tumor investigated for …INVESTIGATED_FOR3 of 3
← investigated for	Pazopanibsmall_molecule	unknown	2	Solitary Fibrous Tumor	1	Curated	chembl	graph →
← investigated for	Eribulinsmall_molecule	unknown	2

Solitary Fibrous Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived18 of 18show fewer
→ investigated in trials for	Bevacizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Trabectedinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Axitinibsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dacarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Gefitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →

Solitary Fibrous Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived18 of 18show fewer

→ investigated in trials for

Bevacizumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Solitary Fibrous Tumor

Observed

Solitary Fibrous Tumor studied in …STUDIED_INderived10 of 29show all (up to 200)
→ studied in	NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06789172Phase 1 · recruiting A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT04008238NA · completed Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03967834NA · recruiting Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Malignant Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02613299terminated Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma · condition mapped ALIAS · 29 trials mapped (3 active)	—	—	Pleural Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02648763terminated Staging Procedures to Diagnose Malignant Pleural Mesothelioma · condition mapped ALIAS · 29 trials mapped (3 active)	—	—	Pleural Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03023124Phase 2 · completed Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT03840772Phase 2 · completed Eribulin in Advanced Solitary Fibrous Tumor · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02613312terminated Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 29 trials mapped (3 active)	—	—	Pleural Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02066285Phase 2 · completed Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma · condition mapped ONTOLOGY_EXACT · 29 trials mapped (3 active)	—	—	Solitary Fibrous Tumor	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains